NCT06095141 2025-08-07
PTCA199-6
Fudan University
Phase 2/3 Recruiting
Clinical Trials
3 trialsNCT05181605 2022-08-09
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors
Instituto de investigación e innovación biomédica de Cádiz
Phase 2/3 Unknown
NCT05268692 2022-03-07
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
Kochi University
Phase 2/3 Recruiting